Fabris, M.; Del Ben, F.; Sozio, E.; Beltrami, A.P.; Cifù, A.; Bertolino, G.; Caponnetto, F.; Cotrufo, M.; Tascini, C.; Curcio, F.
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients. Int. J. Mol. Sci. 2022, 23, 4830.
https://doi.org/10.3390/ijms23094830
AMA Style
Fabris M, Del Ben F, Sozio E, Beltrami AP, Cifù A, Bertolino G, Caponnetto F, Cotrufo M, Tascini C, Curcio F.
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients. International Journal of Molecular Sciences. 2022; 23(9):4830.
https://doi.org/10.3390/ijms23094830
Chicago/Turabian Style
Fabris, Martina, Fabio Del Ben, Emanuela Sozio, Antonio Paolo Beltrami, Adriana Cifù, Giacomo Bertolino, Federica Caponnetto, Marco Cotrufo, Carlo Tascini, and Francesco Curcio.
2022. "Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients" International Journal of Molecular Sciences 23, no. 9: 4830.
https://doi.org/10.3390/ijms23094830
APA Style
Fabris, M., Del Ben, F., Sozio, E., Beltrami, A. P., Cifù, A., Bertolino, G., Caponnetto, F., Cotrufo, M., Tascini, C., & Curcio, F.
(2022). Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients. International Journal of Molecular Sciences, 23(9), 4830.
https://doi.org/10.3390/ijms23094830